A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine

By Dahlöf Carl   Jones Martin   Davis Kim   Loftus Jane   Salonen Reijo  

The Journal of Headache and Pain, Vol. 5, Iss. 2, 2004-08 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Zolmitriptan Formulations Provide Fast Relief in the Acute Treatment of Migraine

By Charlesworth Bruce   Yates Roger  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 72-74

Informa Healthcare

Access to resources Recommend Favorite

Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes: Results of a prospective longitudinal study over one year

By Best Christoph   Eckhardt-Henn Annegret   Tschan Regine   Dieterich Marianne  

Journal of Neurology, Vol. 256, Iss. 1, 2009-01 ,pp. : 58-65

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness and Patient Satisfaction with Zolmitriptan Nasal Spray 5 mg in Clinical Practice: A Patient Survey

By Hansen Steen Boes  

Headache Care, Vol. 2, Iss. 2, 2005-06 ,pp. : 127-136

Informa Healthcare

Access to resources Recommend Favorite

Zolmitriptan Nasal Spray Improves Patient Satisfaction by Providing Fast and Effective Relief from Migraine Symptoms

By Dahlöf Carl   Boes-Hansen Steen   Dowson Andrew  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 85-94

Informa Healthcare

Access to resources Recommend Favorite